SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-013000
Filing Date
2020-06-12
Accepted
2020-06-12 12:18:59
Documents
3
Period of Report
2020-06-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dffn20200610_8k.htm 8-K 18703
2 EXHIBIT 99.1 ex_189977.htm EX-99.1 19630
3 logo.jpg GRAPHIC 5656
  Complete submission text file 0001437749-20-013000.txt   47635
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 20959547
SIC: 2834 Pharmaceutical Preparations